 Acquired Immunodeficiency Syndrome
"Acquired Immunodeficiency Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
| Descriptor ID |
D000163
|
| MeSH Number(s) |
C02.782.815.616.400.040 C02.800.801.400.040 C02.839.040 C20.673.480.040
|
| Concept/Terms |
Acquired Immunodeficiency Syndrome- Acquired Immunodeficiency Syndrome
- Immunologic Deficiency Syndrome, Acquired
- Acquired Immune Deficiency Syndrome
- Acquired Immuno-Deficiency Syndrome
- Acquired Immuno Deficiency Syndrome
- Acquired Immuno-Deficiency Syndromes
- Immuno-Deficiency Syndrome, Acquired
- Immuno-Deficiency Syndromes, Acquired
- Syndrome, Acquired Immuno-Deficiency
- Syndromes, Acquired Immuno-Deficiency
- Immunodeficiency Syndrome, Acquired
- Acquired Immunodeficiency Syndromes
- Immunodeficiency Syndromes, Acquired
- Syndrome, Acquired Immunodeficiency
- Syndromes, Acquired Immunodeficiency
- AIDS
|
Below are MeSH descriptors whose meaning is more general than "Acquired Immunodeficiency Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Acquired Immunodeficiency Syndrome".
This graph shows the total number of publications written about "Acquired Immunodeficiency Syndrome" by people in UAMS Profiles by year, and whether "Acquired Immunodeficiency Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2022 | 4 | 1 | 5 | | 2021 | 1 | 0 | 1 | | 2020 | 1 | 0 | 1 | | 2019 | 1 | 0 | 1 | | 2018 | 2 | 0 | 2 | | 2016 | 1 | 1 | 2 | | 2015 | 2 | 1 | 3 | | 2014 | 1 | 0 | 1 | | 2013 | 2 | 0 | 2 | | 2012 | 1 | 0 | 1 | | 2009 | 1 | 1 | 2 | | 2008 | 2 | 1 | 3 | | 2007 | 1 | 1 | 2 | | 2006 | 1 | 1 | 2 | | 2004 | 2 | 1 | 3 | | 2003 | 1 | 0 | 1 | | 2000 | 0 | 1 | 1 | | 1999 | 1 | 0 | 1 | | 1998 | 0 | 1 | 1 | | 1995 | 1 | 1 | 2 | | 1994 | 1 | 0 | 1 | | 1991 | 0 | 1 | 1 | | 1990 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Acquired Immunodeficiency Syndrome" by people in Profiles over the past ten years.
-
Rajdev L, Jackie Wang CC, Joshi H, Lensing S, Lee J, Ramos JC, Baiocchi R, Ratner L, Rubinstein PG, Ambinder R, Henry D, Streicher H, Little RF, Chiao E, Dittmer DP, Einstein MH, Cesarman E, Mitsuyasu R, Sparano JA. Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study. Cancer. 2024 03 15; 130(6):985-994.
-
Lin LL, Ndlovu N, Lowenstein J, Wirth M, Lee J, Stier EA, Garg M, Kotzen J, Kadzatsa W, Palefsky J, Krown SE, Einstein MH. Quality Assurance in Clinical Trials Requiring Radiation Therapy in Sub-Saharan Africa. Int J Radiat Oncol Biol Phys. 2023 06 01; 116(2):439-447.
-
Punjabi NM, Brown TT, Aurora RN, Patel SR, Stosor V, Hyong-Jin Cho J, D'Souza G, Margolick JB. Prevalence and Predictors of Sleep-Disordered Breathing in Men Participating in the Multicenter AIDS Cohort Study. Chest. 2023 03; 163(3):687-696.
-
Haigentz M, Moore P, Bimali M, Cooley T, Sparano J, Rudek M, Ratner L, Henry D, Ramos J, Deeken J, Rubinstein P, Chiao E. Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study. Oncologist. 2022 08 05; 27(8):623-e624.
-
Wang S, Pasca S, Post WS, Langan S, Pallavajjala A, Haley L, Gocke CD, Budoff M, Haberlen S, Brown TT, Ambinder RF, Margolick JB, Gondek LP. Clonal hematopoiesis in men living with HIV and association with subclinical atherosclerosis. AIDS. 2022 09 01; 36(11):1521-1531.
-
Wada NI, Breen EC, Post WS, Stosor V, Macatangay BJ, Margolick JB. Long-term Trajectories of C-Reactive Protein Among Men Living With and Without HIV Infection in the Multicenter AIDS Cohort Study. J Gerontol A Biol Sci Med Sci. 2022 07 05; 77(7):1382-1388.
-
Mart?nez LE, Lensing S, Chang D, Magpantay LI, Mitsuyasu R, Ambinder RF, Sparano JA, Mart?nez-Maza O, Epeldegui M. Plasma extracellular vesicles bearing PD-L1, CD40, CD40L or TNF-RII are significantly reduced after treatment of AIDS-NHL. Sci Rep. 2022 06 02; 12(1):9185.
-
Rasmussen TA, Rajdev L, Rhodes A, Dantanarayana A, Tennakoon S, Chea S, Spelman T, Lensing S, Rutishauser R, Bakkour S, Busch M, Siliciano JD, Siliciano RF, Einstein MH, Dittmer DP, Chiao E, Deeks SG, Durand C, Lewin SR. Impact of Anti-PD-1 and Anti-CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 Study. Clin Infect Dis. 2021 10 05; 73(7):e1973-e1981.
-
Saccente M, Krishnan G. Comparison of Blood (1->3)-?-d-Glucan Levels in AIDS-Related Pneumocystis jirovecii Pneumonia and AIDS-Related Progressive Disseminated Histoplasmosis. Clin Infect Dis. 2021 09 15; 73(6):1100-1102.
-
Strother RM, Gopal S, Wirth M, Chadburn A, Noy A, Cesarman E, Lee JY, Remick SC, Busakhala N, Kaimila B, Mberi E, Ndlovu N, Omoding A, Krown SE. Challenges of HIV Lymphoma Clinical Trials in Africa: Lessons From the AIDS Malignancy Consortium 068 Study. JCO Glob Oncol. 2020 07; 6:1034-1040.
-
Goldstone SE, Lensing SY, Stier EA, Darragh T, Lee JY, van Zante A, Jay N, Berry-Lawhorn JM, Cranston RD, Mitsuyasu R, Aboulafia D, Palefsky JM, Wilkin T. A Randomized Clinical Trial of Infrared Coagulation Ablation Versus Active Monitoring of Intra-anal High-grade Dysplasia in Adults With Human Immunodeficiency Virus Infection: An AIDS Malignancy Consortium Trial. Clin Infect Dis. 2019 03 19; 68(7):1204-1212.
-
Burkhalter JE, Aboulafia DM, Botello-Harbaum M, Lee JY. Participant characteristics and clinical trial decision-making factors in AIDS malignancy consortium treatment trials for HIV-infected persons with cancer (AMC #S006). HIV Clin Trials. 2018 12; 19(6):235-241.
-
Pei Q, Han X, Zhang Y, Zhang W, Zhou DB. [Clinical Analysis of 10 Cases of AIDS Complicated with Lymphoma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2018 Feb; 26(1):146-152.
-
Bender Ignacio RA, Lee JY, Rudek MA, Dittmer DP, Ambinder RF, Krown SE. Brief Report: A Phase 1b/Pharmacokinetic Trial of PTC299, a Novel PostTranscriptional VEGF Inhibitor, for AIDS-Related Kaposi's Sarcoma: AIDS Malignancy Consortium Trial 059. J Acquir Immune Defic Syndr. 2016 May 01; 72(1):52-7.
-
Klug DJ, Darling MD, Kaley JR, Tchernev G, Chokoeva AA, Wollina U, Lotti T, Fioranelli M, Roccia MG, Maximov GK, Gagnon AL, Patterson JW. Isolated CMV infection causing perianal and sacral ulceration in a patient with aids. J Biol Regul Homeost Agents. 2016 Apr-Jun; 30(2 Suppl 2):13-5.
-
Noy A, Lensing SY, Moore PC, Gupta N, Aboulafia D, Ambinder R, Baiocchi R, Dezube BJ, Henry D, Kaplan L, Levine AM, Mitsuyasu R, Ratner L, Reid E, Remick S, Sparano J, Tzachanis D, Wachsman W, Chadburn A. Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium. Leuk Lymphoma. 2016 07; 57(7):1731-4.
-
Epeldegui M, Lee JY, Mart?nez AC, Widney DP, Magpantay LI, Regidor D, Mitsuyasu R, Sparano JA, Ambinder RF, Mart?nez-Maza O. Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial). Clin Cancer Res. 2016 Jan 15; 22(2):328-36.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|